Juniper Pharma (JNP) Tops Q1 EPS by 11c

Juniper Pharma (NASDAQ: JNP) reported Q1 EPS of $0.03, $0.11 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.13 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Frequency Electronics (FEIM) Tops Q1 EPS by 12c
• TransMedics names new CFO and reiterates 2026 revenue guidance